Not yet taking people in Csehország2. fázis
Low-dose versus standard-dose anticoagulation with argatroban or enoxaparin during extracorporeal membrane oxygenation controlled by anti-IIa or anti-Xa assay
Key facts
- Where
- Ostrava és Prague, CsehországSee the 2 sites
- Phase
- 2. fázis
Where in Csehország
- Fakultni nemocnice OstravaOstrava, CsehországToborzás még nem indult
- Fakultni nemocnice v MotolePrague, CsehországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fakultni Nemocnice Ostrava
- Trial code
- EU 2025-524553-13-00
- Record updated
- 2026. március 19.
- Original description
Description of the efficacy and safety of low dose (LD) and standard dose (SD) anticoagulation with argatroban and enoxaparin in patients on ECMO support.Read full original descriptionShow less
Description of the efficacy and safety of low dose (LD) and standard dose (SD) anticoagulation with argatroban and enoxaparin in patients on ECMO support.
Inclusion: ECMO support with argatroban / enoxaparin anticoagulation; Age ≥ 18 years; Obtaining informed consent according to the procedure specified in the protocol.
Exclusion: Inclusion in the lung transplant program at Motol Hospital; Known hypersensitivity to components of the investigational medicinal products; Allergic reaction to the active substances of the investigational medicinal products; Pregnancy and breastfeeding.